Beryl Drugs Limited (BERLDRG.BO)
- Previous Close
19.50 - Open
19.50 - Bid 18.80 x --
- Ask 19.50 x --
- Day's Range
19.50 - 19.50 - 52 Week Range
17.35 - 43.70 - Volume
290 - Avg. Volume
2,958 - Market Cap (intraday)
98.898M - Beta (5Y Monthly) 0.10
- PE Ratio (TTM)
121.88 - EPS (TTM)
0.16 - Earnings Date May 30, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Beryl Drugs Limited engages in the manufacture and marketing of various branded and generic pharmaceutical formulations in India. The company offers bulk drugs, such as I.V. fluids and small volume injectables, as well as veterinary products. It is also involved in the research and development, and contract manufacturing services. The company also exports its products. Beryl Drugs Limited was incorporated in 1993 and is based in Indore, India.
www.beryldrugs.com--
Full Time Employees
March 31
Fiscal Year Ends
Sector
Recent News: BERLDRG.BO
View MorePerformance Overview: BERLDRG.BO
Trailing total returns as of 6/6/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BERLDRG.BO
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BERLDRG.BO
View MoreValuation Measures
Market Cap
98.90M
Enterprise Value
141.52M
Trailing P/E
121.88
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.50
Price/Book (mrq)
1.06
Enterprise Value/Revenue
0.71
Enterprise Value/EBITDA
6.57
Financial Highlights
Profitability and Income Statement
Profit Margin
2.74%
Return on Assets (ttm)
5.21%
Return on Equity (ttm)
6.28%
Revenue (ttm)
211.46M
Net Income Avi to Common (ttm)
5.79M
Diluted EPS (ttm)
0.16
Balance Sheet and Cash Flow
Total Cash (mrq)
8.14M
Total Debt/Equity (mrq)
42.86%
Levered Free Cash Flow (ttm)
2.67M